Oral small-molecule therapies, including JAK inhibitors and S1P receptor modulators, represent a promising shift in the treatment landscape. These agents offer targeted immunomodulation without the ...
Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have ...
Researchers at City St. George’s, University of London, have identified a new molecular signature that may explain why ...
Hetero Labs Ltd. has identified angiopoietin-1 receptor (TEK; hTIE2), EGFR (HER1; erbB1), hepatocyte growth factor receptor (HGFR; MET), proto-oncogene tyrosine-protein kinase receptor ret (RET; ...
Antitumour necrosis factor alpha (anti-TNFα) agents include infliximab, adalimumab, golimumab, AVX-470 and OPRX-106. Janus kinase (JAK) inhibitors: tofacitinib, filgotinib and upadacitinib. Cytokine ...
EQ504 data to be presented in three poster presentations next week at the annual meeting of the American Association of Immunologists (AAI) LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium, Inc. (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results